Forschungsgebiete

  • Formulation of Proteins
  • Drug Delivery
  • Composite Biomaterials

Kurzlebenslauf

  • 1989 Pharmacy degree, Erlangen
  • 1993 PhD, Erlangen
  • 1994-1995 Postdoctoral Researcher , Erlangen
  • 1995-1996 Visiting Postdoctoral Researcher, University of Illinois, Chicago/USA
  • 1996-1997 Staff Scientist, Genetics Institute, Wyeth Ayerst, Andover, MA/USA
  • 1997-2000 Research Assistant, Erlangen
  • 2000 Habilitation
  • Since 2001 Professor (C3) for Pharmaceutical Technology and Biopharmaceutics, LMU

Wichtige Publikationen

  • Matheus S, Mahler H-C, Friess W (2006) A Critical Evaluation of Tm(FTIR) Measurements of High-Concentration IgG1 Antibody Formulations as a Formulation Development Tool. Pharm. Res. 23: 1617-1627.
  • Hawe A, Frieß W (2007) Stabilization of a hydrophobic recombinant cytokine by human serum albumin. J. Pharm Sci. 96: 2987-2999.
  • Metzmacher I, Radu F, Bause M, Knabner P, Friess W (2007) A model describing the effect of enzymatic degradation on drug release from collagen minirods. Eur. J. Pharm. Biopharm. 67: 349-360.